NewsBenzingaBTIG bekräftigt Kaufempfehlung für Aldeyra Therapeutics und belässt das Kursziel bei 9 $ BTIG bekräftigt Kaufempfehlung für Aldeyra Therapeutics und belässt das Kursziel bei 9 $ Benzinga 2026.09.29 16:30 (GMT+0) Open on Benzinga Other news Elon Musk’s Mom Proudly Posts His 1989 Aptitude Test Showing ‘Outstanding’ and A+ Scores at Just 17 — 'My Genius Boy’ OpenAI takes on Microsoft with the launch of what feels a whole lot like ChatGPT’s own office suite Unusual Put Option Volume in Tetra Tek Stock May Signal Investors Are Bullish AI-powered app maker Wabi pivots to a messaging experience 'Beyond Spring and Fall': Apple Prepares Organization Restructure for Accelerating Product Launches Nokia Deepfield Cloud Intelligence Expands Across Zain KSA Network
Elon Musk’s Mom Proudly Posts His 1989 Aptitude Test Showing ‘Outstanding’ and A+ Scores at Just 17 — 'My Genius Boy’
